Literature DB >> 12695555

Profile of aberrant CpG island methylation along multistep gastric carcinogenesis.

Gyeong Hoon Kang1, Sun Lee, Jung-Sun Kim, Hwoon-Yong Jung.   

Abstract

The stomach is one of the organs whose epithelial cells frequently undergo aberrant methylation of CpG islands. To date, several reports on the methylation of various genes in gastric cancer (GC) have been published. However, most of these studies have focused on cancer tissues or a single gene only and gave no information about the methylation status of specific genes in the premalignant stages or the concurrent methylation of other genes in specific lesions. We attempted to investigate methylation of multiple genes in a large sample collection of GC (n = 80), gastric adenoma (GA) (n = 79), intestinal metaplasia (IM) (n = 57), and chronic gastritis (CG) (n = 74). We determined the methylation frequency of 12 genes, including APC, COX-2, DAP-kinase, E-cadherin, GSTP1, hMLH1, MGMT, p16, p14, RASSF1A, THBS1, and TIMP3, by methylation-specific PCR. Five different classes of methylation behaviors were found: (a). genes methylated in GC only (GSTP1 and RASSF1A), (b). genes showing low methylation frequency (<12%) in CG, IM, and gastric adenoma (GA) but significantly higher methylation frequency in GC (COX-2, hMLH1, p16), (c). a gene with low and similar methylation frequency (8.8-21.3%) in four-step lesions (MGMT), (d). genes with high and similar methylation frequency (53-85%) in four-step lesions (APC and E-cadherin), and (e). genes showing an increasing tendency with or without fluctuation of the methylation frequency along the progression (DAP-kinase, p14, THBS1, and TIMP-3). The average number of methylated genes was 2.7, 3.6, 3.4, and 5.2 per 12 tested genes in CG, IM, GA, and GC, respectively. Aberrant methylation at multiple loci in the same lesions suggests an overall deregulation of the methylation control, which occurs early in multistep gastric carcinogenesis. Our results suggest that tumor-suppressor genes show a gene-type specific methylation profile along the multistep carcinogenesis and that aberrant CpG island methylation tend to accumulate along the multistep carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695555     DOI: 10.1097/01.lab.0000064704.53132.65

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  36 in total

1.  Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer.

Authors:  Barbara G Schneider; Dun-Fa Peng; M Constanza Camargo; M Blanca Piazuelo; Liviu A Sicinschi; Robertino Mera; Judith Romero-Gallo; Alberto G Delgado; Luis E Bravo; Keith T Wilson; Richard M Peek; Pelayo Correa; Wael El-Rifai
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

2.  Diminished expression of MGMT & RASSF1A genes in gastric cancer in ethnic population of Kashmir.

Authors:  Arif Akbar Bhat; Hilal Ahmad Wani; Ajaz Ahmad Waza; Rawoof Ahmad Malik; Akbar Masood; Showkat Jeelani; Showkat Kadla; Sabhiya Majid
Journal:  J Gastrointest Oncol       Date:  2016-12

3.  Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.

Authors:  Thomas Fleischer; Arnoldo Frigessi; Kevin C Johnson; Hege Edvardsen; Nizar Touleimat; Jovana Klajic; Margit Lh Riis; Vilde D Haakensen; Fredrik Wärnberg; Bjørn Naume; Aslaug Helland; Anne-Lise Børresen-Dale; Jörg Tost; Brock C Christensen; Vessela N Kristensen
Journal:  Genome Biol       Date:  2014-08-22       Impact factor: 13.583

4.  Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosae.

Authors:  Keisuke Kosumi; Yoshifumi Baba; Takatsugu Ishimoto; Kazuto Harada; Keisuke Miyake; Daisuke Izumi; Ryuma Tokunaga; Asuka Murata; Kojiro Eto; Hidetaka Sugihara; Hironobu Shigaki; Shiro Iwagami; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Masayuki Watanabe; Yoshihiro Komohara; Motohiro Takeya; Hideo Baba
Journal:  Med Oncol       Date:  2015-03-18       Impact factor: 3.064

5.  Promoter CpG island hypermethylation during breast cancer progression.

Authors:  So Yeon Park; Hyeong Ju Kwon; Hee Eun Lee; Han Suk Ryu; Sung-Won Kim; Jee Hyun Kim; In Ah Kim; Namhee Jung; Nam-Yun Cho; Gyeong Hoon Kang
Journal:  Virchows Arch       Date:  2010-12-01       Impact factor: 4.064

6.  Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.

Authors:  Yeonjoo Jung; Jinah Park; Tai Young Kim; Jung-Hyun Park; Hyun-Soon Jong; Seock-Ah Im; Keith D Robertson; Yung-Jue Bang; Tae-You Kim
Journal:  J Mol Med (Berl)       Date:  2007-06-15       Impact factor: 4.599

Review 7.  Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.

Authors:  Hasan Raza Kazmi; Soni Kumari; Satendra Tiwari; A Khanna; Gopeshwar Narayan
Journal:  Pathol Oncol Res       Date:  2018-03-19       Impact factor: 3.201

8.  Aberrant CpG island methylation in early-onset sporadic gastric carcinoma.

Authors:  Hee Cheol Kim; Jin Cheon Kim; Sun Ae Roh; Chang Sik Yu; Jeong Hwan Yook; Sung Tae Oh; Byung Sik Kim; Kun Choon Park; Rin Chang
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-01       Impact factor: 4.553

9.  Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm.

Authors:  Nam-Yun Cho; Jung Ho Kim; Kyung Chul Moon; Gyeong Hoon Kang
Journal:  Virchows Arch       Date:  2008-12-02       Impact factor: 4.064

10.  Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance.

Authors:  Dorra Ben Ayed-Guerfali; Basma Hassairi; Abdelmajid Khabir; Tahia Sellami-Boudawara; Ali Gargouri; Raja Mokdad-Gargouri
Journal:  Tumour Biol       Date:  2013-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.